MDLN
Medline Inc.
NASDAQ · USHealthcareMedical - Instruments & Supplies
$38.88-2.29%
Price as of Jul 20, 2026
MDLN profitability
Medline Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 24.0%
- EBITDA margin
- 9.4%
- EBIT margin
- 7.0%
- Net margin
- 3.3%
- Free cash flow margin
- 5.2%
Returns
- Return on equity
- 8.6%
- Return on assets
- 2.5%
- Return on invested capital
- 8.6%
- Asset turnover
- 0.75x
Cash efficiency
- Cash from operations
- $1.5B
- Cash per share
- $2.64
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.